Source: WUNC, 7/28/22

In a deal that chief executive officer Adam Schechter said creates more opportunities for clinical trials "than there have ever been before," Burlington-based Labcorp will split in two. One company, which will retain the Labcorp name, will focus on providing laboratory tests and services to doctors and hospitals. The other, not yet named, will manage clinical trials and technology solutions for pharmaceutical companies.

For more of this story, click here.